Trending Topic

< 1 min

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

This corrects the article: “Ioannou A. Evolution of Disease-modifying Therapy for Transthyretin Cardiac Amyloidosis. Heart International. 2024;18(1):30-37”. Two typography errors were included incorrectly due to an editorial error. In Table 1, “eplontersen” was incorrectly written as “eplomtersen”. This has been corrected in the text. In the section “Eplontersen”, the administration schedule should be written as […]

M. Chadi Alraies, ESC 2018 – End-stage Renal Disease (ESRD) and Peripheral Intervention

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Aug 31st 2018

Dr M. Chadi Alraies (Wayne State University, Detroit Medical Center, Detroit, MI, USA) discusses the background, rationale and results of end-stage renal disease (ESRD) and peripheral intervention trial, presented at ESC 2018.

 

Filmed at ESC 2018, Munich.

View more content here.

Speaker Disclosure: Dr M. Chadi Alraies has nothing to disclose in relation to this video interview.

Questions:

1. What was the background of the trial into end-stage renal disease (ESRD) and peripheral intervention? (0:08)

2. What were the key results of the trial? (0:49)

3. What are the next steps for this area of research? (1:41)

4. What are your highlights from this year’s ESC meeting? (2:25)

 

touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via open-access content in multimedia formats.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup